Stocks and Investing Stocks and Investing
Wed, April 5, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Steve Valiquette Maintained (SNDA) at Sell with Decreased Target to $5 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Manan Gosalia Maintained (SNV) at Hold with Decreased Target to $30 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Timothy Wojs Maintained (AYI) at Hold with Decreased Target to $175 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Brian Lee Maintained (AYI) at Hold with Decreased Target to $173 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Elyse Greenspan Maintained (AXS) at Sell with Decreased Target to $58 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Betsy Graseck Maintained (AXP) at Buy with Increased Target to $188 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
David George Maintained (AXP) at Buy with Decreased Target to $185 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Betsy Graseck Maintained (BAC) at Hold with Decreased Target to $31 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Timur Braziler Maintained (BANC) at Buy with Decreased Target to $18 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Ryan Nash Maintained (BFH) at Hold with Decreased Target to $36 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Betsy Graseck Maintained (BFH) at Hold with Decreased Target to $32 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Craig Siegenthaler Maintained (BEN) at Sell with Decreased Target to $24 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Pavel Molchanov Downgraded (BE) to Buy and Decreased Target to $25 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Alex Scott Maintained (BHF) at Hold with Decreased Target to $50 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
John Edwards Maintained (BHF) at Hold with Decreased Target to $46 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Stephen Trent Maintained (AAL) at Hold with Decreased Target to $16 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
David George Upgraded (ZION) to Buy and Held Target at $60 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Manan Gosalia Maintained (ZION) at Hold with Decreased Target to $34 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Scott Fidel Reiterated (ADUS) at Buy and Held Target at $123 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Glenn Schorr Maintained (BK) at Hold with Decreased Target to $46 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Steven Shaw Maintained (BKU) at Hold with Decreased Target to $30 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Logan Purk Upgraded (ACN) to Strong Buy on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Joseph Feldman Reiterated (ACI) at Hold and Held Target at $27 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Ed Arce Reiterated (ABUS) at Strong Buy and Held Target at $6 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Larry Biegelsen Maintained (ABT) at Buy with Decreased Target to $136 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Wamsi Mohan Maintained (AAPL) at Hold with Increased Target to $168 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Kyle Mcnealy Maintained (AAPL) at Strong Buy and Held Target at $195 on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Jasper Hellweg Downgraded (ABBV) to Hold on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
Leland Gershell Downgraded (ASND) to Hold on, Apr 5th, 2023
[ Wed, Apr 05th 2023 ] - WOPRAI
David Lebowitz Maintained (ASND) at Strong Buy with Decreased Target to $146 on, Apr 5th, 2023

David Lebowitz Maintained (ASND) at Strong Buy with Decreased Target to $146 on, Apr 5th, 2023


Published on 2024-10-28 02:35:32 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Citigroup, Maintained "Ascendis Pharma A/S" (ASND) at Strong Buy with Decreased Target from $163 to $146 on, Apr 5th, 2023.

David has made no other calls on ASND in the last 4 months.



There are 5 other peers that have a rating on ASND. Out of the 5 peers that are also analyzing ASND, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months

  • Vikram Purohit of "Morgan Stanley" Downgraded from Buy to Hold and Decreased Target to $108 on, Tuesday, April 4th, 2023
  • Tiago Fauth of "Credit Suisse" Downgraded from Buy to Hold on, Monday, April 3rd, 2023


These are the ratings of the 3 analyists that currently disagree with David

  • Tazeen Ahmad of "B of A Securities" Maintained at Strong Buy with Decreased Target to $92 on, Tuesday, April 4th, 2023
  • Joseph Schwartz of "SVB Leerink" Maintained at Buy with Increased Target to $163 on, Tuesday, January 17th, 2023
  • Derek Archila of "Wells Fargo" Maintained at Buy with Increased Target to $177 on, Tuesday, January 3rd, 2023
Contributing Sources